Advanced Search
Current and Breaking News for Professionals, Consumers and Media

Click here to learn how to advertise on this site and for ad rates.

Patient Issues Author: Staff Editor Last Updated: Jan 21, 2014 - 3:07:23 PM

Malaria Drug Combo Could Help Prevent Pregnancy Complications in Lupus Patients

By Staff Editor
Jan 21, 2014 - 3:03:33 PM

Email Newsletter icon, E-mail Newsletter icon, Email List icon, E-mail List icon Sign up for our Ezine
For Email Marketing you can trust

Email this article
 Printer friendly page

( - New Haven, Conn.- An anti-malaria drug combination might be useful in helping to prevent pregnancy complications in women with lupus and the related disorder antiphospholipid syndrome, Yale School of Medicine researchers have found in a new study published in the American Journal of Reproductive Immunology.

Circulating antibodies called antiphospholipid antibodies are normally produced by the body to recognize and attack bacteria and other microbe. In those with lupus and/or antiphospholipid syndrome, however, these antibodies recognize and attack the body's own proteins, putting women at high risk for recurrent pregnancy loss and late gestational complications, such as preeclampsia.

Patients with lupus or antiphospholipid syndrome are often treated with the anti-malarial drug hydroxychloroquine. While the drug can be safely continued during pregnancy, it was unknown whether it might be beneficial in preventing pregnancy complications in women with lupus and/or antiphospholipid syndrome.

In this new study, senior author Vikki M. Abrahams, associate professor in the Department of Obstetrics, Gynecology & Reproductive Sciences at Yale, and first author and Yale medical student Caroline Albert explored whether the drug could treat obstetrical antiphospholipid syndrome.

Abrahams and Albert used a lab-based system to measure the detrimental effects of antiphospholipid antibodies on human placental trophoblast cell function.

"We found that hydroxychloroquine partially reversed some, but not all, of the detrimental effects of antiphospholipid antibodies on human placental cell function," said Abrahams. "So perhaps some form of combination therapy that includes hydroxychloroquine may be beneficial to pregnant patients with lupus and/or antiphospholipid syndrome."

Other authors on the study include William J. Schlesinger, Chez A. Viall, Melissa J. Mulla, Jan J. Brosens, and Lawrence W. Chamley.

The study was funded by grants from the Lupus Foundation of America and the March of Dimes. Caroline Albert was supported by the 2012 Lupus Foundation of America Gina M. Finzi Memorial Student Summer Fellowship.

Citation: American Journal of Reproductive Immunology (Jan. 2014)


For advertising and promotion on, call Mike McCurdy: 877-634-9180 or [email protected] We have over 7,000 journalists as subscribers.


Top of Page

Patient Issues
Latest Headlines

+ Strengthen Safety Net for People with Rare and Chronic Disorders to Access Vital Health Care
+ TouchCare Adds Web-Based Admin Support, Direct Patient Billing Capabilities
+ Catch Them Before They Fall
+ ‘Personalized medicine’ Drives Better Outcomes for Certain Heart Patients
+ Herniated Disc? Treatment Options are Plentiful
+ Are Hospitals Telling Patients About Charity Care Options?
+ Would Washington's FDA Fix Cure the Patients or the Drug Industry?
+ Living Well with Chronic Pain – The Choice You Have to Make
+ Mission Pharmacal Relaunches Product to Help Kidney Stone Patients
+ Protein-Rich Nutrition Key to Helping Patients Recover from Severe Burns

Contact Us | Job Listings | Help | Site Map | About Us
Advertising Information | HND Press Release | Submit Information | Disclaimer

Site hosted by Sanchez Productions